DE60300021T2 - que- - Google Patents

que- Download PDF

Info

Publication number
DE60300021T2
DE60300021T2 DE60300021T DE60300021T DE60300021T2 DE 60300021 T2 DE60300021 T2 DE 60300021T2 DE 60300021 T DE60300021 T DE 60300021T DE 60300021 T DE60300021 T DE 60300021T DE 60300021 T2 DE60300021 T2 DE 60300021T2
Authority
DE
Germany
Prior art keywords
compound
piperidinylmethyl
amino
tetrahydrofurylcarbonyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60300021T
Other languages
German (de)
English (en)
Other versions
DE60300021D1 (de
Inventor
Shiro Sakai-shi KATO
Hiroshi Suita-shi Yamazaki
Yoshimi Ikoma-shi Hirokawa
Yoko Suita-shi Kan
Naoyuki Sakai-shi YOSHIDA
Kazuo Suita-shi MORIKAGE
Yukiko Suita-shi MORIKAGE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of DE60300021D1 publication Critical patent/DE60300021D1/de
Application granted granted Critical
Publication of DE60300021T2 publication Critical patent/DE60300021T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60300021T 2002-05-16 2003-01-03 que- Expired - Fee Related DE60300021T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002141262 2002-05-16
JP2002141262 2002-05-16

Publications (2)

Publication Number Publication Date
DE60300021D1 DE60300021D1 (de) 2004-09-16
DE60300021T2 true DE60300021T2 (de) 2005-09-08

Family

ID=29267809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60300021T Expired - Fee Related DE60300021T2 (de) 2002-05-16 2003-01-03 que-

Country Status (26)

Country Link
US (1) US6696468B2 (https=)
EP (1) EP1362857B1 (https=)
JP (1) JP3643107B2 (https=)
KR (1) KR20040107520A (https=)
CN (1) CN1653063A (https=)
AR (1) AR040021A1 (https=)
AT (1) ATE273304T1 (https=)
AU (1) AU2003230245A1 (https=)
BR (1) BR0309933A (https=)
CA (1) CA2483368A1 (https=)
CZ (1) CZ20041084A3 (https=)
DE (1) DE60300021T2 (https=)
DK (1) DK1362857T3 (https=)
ES (1) ES2227500T3 (https=)
HU (1) HUP0501016A2 (https=)
IL (1) IL165012A0 (https=)
MX (1) MXPA04011332A (https=)
NO (1) NO20045469L (https=)
PL (1) PL372724A1 (https=)
PT (1) PT1362857E (https=)
RU (1) RU2004136853A (https=)
SK (1) SK50192004A3 (https=)
TR (1) TR200403020T2 (https=)
TW (1) TW200400186A (https=)
WO (1) WO2003097638A1 (https=)
ZA (1) ZA200409053B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
SE0200844D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0200843D0 (sv) 2002-03-19 2002-03-19 Astrazeneca Ab Chemical compounds
SE0300957D0 (sv) 2003-04-01 2003-04-01 Astrazeneca Ab Chemical compounds
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7399862B2 (en) * 2004-11-05 2008-07-15 Theravance, Inc. 5-HT4 receptor agonist compounds
WO2006052889A2 (en) * 2004-11-05 2006-05-18 Theravance, Inc. Quinolinone-carboxamide compounds
CA2588037A1 (en) * 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
CN101163701A (zh) * 2005-03-02 2008-04-16 施万制药 作为5-ht4受体激动剂的喹啉酮化合物
US7256294B2 (en) * 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound
MY147756A (en) 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
TW200722419A (en) * 2005-05-27 2007-06-16 Astrazeneca Ab Chemical compounds
US20080200505A1 (en) * 2005-05-27 2008-08-21 Astrazeneca Ab Piperidines for the Treatment of Chemokine Mediated Diseases
WO2007011293A1 (en) 2005-07-21 2007-01-25 Astrazeneca Ab Novel piperidine derivatives
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
AR086554A1 (es) 2011-05-27 2014-01-08 Novartis Ag Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina
JP2015525202A (ja) 2012-05-03 2015-09-03 ノバルティス アーゲー グレリン受容体アゴニストとしての２，７−ジアザ−スピロ［４，５］デカ−７−イル誘導体のｌ−リンゴ酸塩およびその結晶形態
IL297456A (en) * 2020-05-04 2022-12-01 Takeda Pharmaceuticals Co n-(piperidin-4-yl)benzamide derivatives are active in Nahor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111472A (ja) 1996-04-30 1999-01-06 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びそれを含有する医薬組成物
EP1076055B1 (en) * 1998-04-28 2004-11-24 Dainippon Pharmaceutical Co., Ltd. 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
JP2000080081A (ja) 1998-06-24 2000-03-21 Dainippon Pharmaceut Co Ltd １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物
JP2001122784A (ja) 1999-10-27 2001-05-08 Dainippon Pharmaceut Co Ltd １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬

Also Published As

Publication number Publication date
PL372724A1 (en) 2005-07-25
HK1060118A1 (en) 2004-07-30
HUP0501016A2 (en) 2006-02-28
ZA200409053B (en) 2005-07-12
KR20040107520A (ko) 2004-12-20
US20030216433A1 (en) 2003-11-20
DE60300021D1 (de) 2004-09-16
TR200403020T2 (tr) 2005-05-23
EP1362857A1 (en) 2003-11-19
US6696468B2 (en) 2004-02-24
BR0309933A (pt) 2005-02-09
AR040021A1 (es) 2005-03-09
DK1362857T3 (da) 2004-12-20
AU2003230245A1 (en) 2003-12-02
SK50192004A3 (sk) 2005-04-01
ES2227500T3 (es) 2005-04-01
IL165012A0 (en) 2005-12-18
EP1362857B1 (en) 2004-08-11
MXPA04011332A (es) 2005-02-14
ATE273304T1 (de) 2004-08-15
CZ20041084A3 (cs) 2005-02-16
JP3643107B2 (ja) 2005-04-27
WO2003097638A1 (en) 2003-11-27
CN1653063A (zh) 2005-08-10
CA2483368A1 (en) 2003-11-27
JP2004043453A (ja) 2004-02-12
TW200400186A (en) 2004-01-01
RU2004136853A (ru) 2005-06-27
NO20045469L (no) 2005-02-16
PT1362857E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
DE60300021T2 (de) que-
DE69922186T2 (de) 1-(1-subst.-4-piperidinyl)methyl]-4-piperidin-derivate, verafhren zu deren herstellung, pharmazeutische mixturen und intermediate zu deren herstellung
DE69820065T2 (de) Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative
DE69728768T2 (de) 2,4-diaminopyrimidine derivates als dopamine d4 rezeptorantagonisten
DE69103206T2 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
DE3218584A1 (de) 1,2-diaminocyclobuten-3,4-dione, verfahren zu deren herstellung und pharmazeutische mittel, die diese verbindungen enthalten
DE69818678T2 (de) (+)-norcisapride verwendbar bei 5-ht3 und 5-ht4 bedingten krankheiten
DE69721742T2 (de) N-substituierte 4-((4'-aminobenzoyl)-oxymethyl)-piperidine mit gastrokinetischen eigenschaften
DE2238504B2 (de) l-Phenoxy-3-alkylaminopropan-2-ol -Derivate
DE69612753T2 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
DE69629023T2 (de) Piperazino-derivative als neurokininantagonisten
DD290186A5 (de) Verfahren zur herstellung von piperidinderivaten
DE69513846T2 (de) N-substituierte piperidinyl bicyclische benzoatderivate
DE69232484T2 (de) Hydroisochinolinderivate
DE2434951B2 (de) In 3-stellung basisch substituierte diphenylhydantoine
DE60009287T2 (de) Neuartige isoquinolin-derivate oder salze davon
DE69815518T2 (de) S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonist
DD281596A5 (de) Verfahren zur hersteung antiarrhytmischer mittel
EP0254955B1 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2720545A1 (de) Neue chinazolinderivate, ihre herstellung und pharmazeutische mittel
CH678322A5 (https=)
DE2852088A1 (de) Substituierte pyrrolidine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
DE69622415T2 (de) 12H-Dibenzo[d,g][1,3]dioxocin Derivate
DE69328495T2 (de) 2,3-Dihydrobenzofuran Derivate
DE2734270C2 (https=)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee